The ALK inhibitor ASP3026 eradicates NPM-ALK? T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model
| author | |
| created | [InstanceEdit:9702303] Rothfels, Karen, 2020-09-29 |
| dbId | 9702302 |
| displayName | The ALK inhibitor ASP3026 eradicates NPM-ALK? T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model |
| journal | Oncotarget |
| pages | 5750-63 |
| pubMedIdentifier | 25026277 |
| schemaClass | LiteratureReference |
| title | The ALK inhibitor ASP3026 eradicates NPM-ALK? T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model |
| url | http://www.ncbi.nlm.nih.gov/pubmed/25026277 |
| volume | 5 |
| year | 2014 |
Referrals
| (literatureReference) | |
| (author) |
© 2026 Reactome
